The independent source for health policy research, polling, and news.
201-220 of 388 results
An average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by âthe crackhouse statute,â a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.
President Donald Trump keeps promising a new health plan, but so far itâs nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHNâs Julie Rovner to discuss these issues and more. Rovner also interviews KHNâs Rachel Bluth about the latest âBill of the Monthâ feature. Plus, for âextra credit,â the panelists recommend their favorite health stories of the week.
As schools begin a new year, more districts will test students as young as 11 for illicit drug use even as other drug prevention efforts are scaled back. More than 1 in 3 school districts nationwide give students drug tests.
New research published in JAMA Network Open quantified for the first time international differences in doctorsâ prescribing habits and patientsâ use of these highly addictive painkillers.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patientsâ pain, the nationâs sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHNâs Julie Rovner to discuss this, plus court actions on health issues.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitorsâ âMedicare for Allâ plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHNâs Julie Rovner to discuss this, plus Planned Parenthoodâs very bad week, the U.S. House vote to repeal the health lawâs âCadillac taxâ on generous health plans, and the reduction in deaths from opioids.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A new report by the inspector general for HHS shows prescriptions to treat opioid addiction are way up in recent years, while prescriptions for the painkillers have fallen.
Š 2026 KFF